INSTITUT CURIE;INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM)
发明人:
Sebastian AMIGORENA,Eliane PIAGGIO,Leticia NIBORSKI
申请号：
US16773192
公开号：
US20200157225A1
申请日:
2020.01.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to an inhibitor of H3K9 histone methyl transferase SUV39H1 for use in combination with at least one immune checkpoint modulator in the treatment of cancer.
